Crystal structure, Hirshfeld surface analysis and DFT studies of 6-bromo-3-(12-bromo­dodec­yl)-2-(4-nitro­phen­yl)-4H-imidazo[4,5-b]pyridine

The title compound, C(24)H(30)Br(2)N(4)O(2), consists of a 2-(4-nitro­phen­yl)-4H-imidazo[4,5-b]pyridine entity with a 12-bromo­dodecyl substituent attached to the pyridine N atom. The middle eight-carbon portion of the side chain is planar to within 0.09 (1) Å and makes a dihedral angle of 21.9 (8)° with the mean plane of the imidazolo­pyridine moiety, giving the mol­ecule a V-shape. In the crystal, the imidazolo­pyridine units are associated through slipped π–π stacking inter­actions together with weak C—H(Pyr)⋯O(Ntr) and C—H(Brmdc­yl)⋯O(Ntr) (Pyr = pyridine, Ntr = nitro and Brmdcyl = bromo­dodec­yl) hydrogen bonds. The 12-bromo­dodecyl chains overlap with each other between the stacks. The terminal –CH(2)Br group of the side chain shows disorder over two resolved sites in a 0.902 (3):0.098 (3) ratio. Hirshfeld surface analysis indicates that the most important contributions for the crystal packing are from H⋯H (48.1%), H⋯Br/Br⋯H (15.0%) and H⋯O/O⋯H (12.8%) inter­actions. The optimized mol­ecular structure, using density functional theory at the B3LYP/ 6–311 G(d,p) level, is compared with the experimentally determined structure in the solid state. The HOMO–LUMO behaviour was elucidated to determine the energy gap.